top of page

Trastuzumab Deruxtecan for Cancer: Before You Start, What I Tell My Patients & Their Families (HER2, Side Effects & Cost)

🧠 TL;DR

  • Trastuzumab Deruxtecan is a HER2-targeted antibody-drug conjugate (ADC)

  • Combines targeting + chemotherapy in one molecule

  • Used in HER2-positive and HER2-low breast cancer, gastric & some lung cancers

  • Given once every 3 weeks (half-life ~6 days)

  • ❌ NOT the same as trastuzumab (Herceptin) or T-DM1 → common dangerous confusion

  • ⚠️ Major risks: lung toxicity (ILD), heart dysfunction, bone marrow suppression

  • 💰 Cost varies widely → depends on weight, schemes & support programs

👉 Not sure if this drug is right for you?[Consult Dr. Bharat for a second opinion]

👨‍⚕️ How I Started a Discussion with a Patient

When I start a patient on Trastuzumab Deruxtecan, the first thing I clarify is:

👉 “This is not the same as trastuzumab.”

And this single misunderstanding leads to a surprising number of real-world errors.

In my practice, I frequently see:

  • Wrong HER2 drug being given

  • Dose confusion between similar-sounding drugs

  • Patients started without proper evaluation

This is a powerful drug, but it demands precision, experience, and correct selection.


🧬 What is Trastuzumab Deruxtecan?

This is a HER2-directed antibody-drug conjugate (ADC).

👉 Simple explanation:

  • One part = trastuzumab (targets HER2 receptor on cancer cells)

  • Second part = deruxtecan (chemotherapy that damages DNA)

👉 So effectively: Targeted delivery of chemotherapy inside cancer cells


⚠️ MOST IMPORTANT: These HER2 Drugs Are NOT the Same

This is one of the most dangerous mistakes I see.

These are DIFFERENT drugs:

  • Trastuzumab (Herceptin)

  • Trastuzumab emtansine (T-DM1)

  • Trastuzumab deruxtecan (Enhertu)

👉 They are:

  • Not interchangeable

  • Not dose-equivalent

  • Not substitutes


🚨 Clinical Reality

I regularly get consultations where:

  • One drug was given instead of another

  • Dosing confusion occurred

  • Substitution was assumed because of the “same HER2 family.”

👉 This can lead to:

  • Serious toxicity

  • Reduced treatment effectiveness

  • Avoidable complications


📍 Where Is It Used?

As of 2026:

  • HER2-positive breast cancer

  • HER2-low breast cancer (very important evolving concept)

  • Gastric cancer

  • Selected lung cancers



🧠 Clinical Pearl: HER2-Low Is a Game Changer

Earlier:

  • Only HER2 3+ was considered positive

Now:

  • Even HER2 1+ or low expression may respond

👉 This is where many patients need: Re-evaluation of reports before starting treatment


⏳ Dose & Schedule

  • Standard dose: 5.4 mg/kg every 3 weeks

  • Gastric cancer: 6.4 mg/kg



⚠️ Dose Modification (Simplified for Patients)

  • Mild side effects (Grade 1–2) → dose reduction (~20%)

  • Severe side effects (Grade 3–4) → stop drug

👉 Severe = organ damage requiring hospitalization


⚠️ Who Should Be VERY Careful?

❤️ Heart Function

  • Can reduce heart pumping (EF)

  • Avoid if EF < 50%

👉 Usually reversible if detected early

🫁 Lung Disease (MOST IMPORTANT RISK)

  • Can cause interstitial lung disease (ILD)

  • Occurs in up to 10% patients

🧠 Key Clinical Insight

👉 ILD usually appears around 5 months

So patients often ask:

👉 “Why did this happen late?”

Because: Side effects follow timelines, not all happen immediately

🫁 Symptoms to Watch

  • Breathlessness

  • Dry cough

  • Fatigue

👉 Often mistaken for an infection


🚨 Why Early Detection Matters

Delayed diagnosis can:

  • Worsen lung damage

  • Become life-threatening

👉 This is where experience matters most



🩺 Kidney & Other Risk Factors

  • Kidney dysfunction increases risk

  • Drug clearance affected



🤰 Pregnancy, Fertility & Breastfeeding

❌ Pregnancy

  • Causes fetal abnormalities

  • Skeletal deformities reported

  • Can lead to fetal death

👉 Avoid completely

👉 Gap required:

  • 7 months after the last dose

🧬 Fertility Preservation

  • Sperm banking

  • Egg preservation

👉 We guide patients before starting therapy

❌ Breastfeeding

  • Avoid during treatment

  • Avoid for 7 months after the last dose


⚠️ Side Effects: What to Expect

Chemotherapy Component

  • Low hemoglobin

  • Low WBC

  • Low platelets

  • Nausea, vomiting

  • Body pain

👉 ~20% patients

Targeted Component

  • Heart dysfunction (<10%)

Lung Toxicity (ILD)

  • Up to 10%

  • Most critical side effect

Other Side Effects

  • Swelling (legs, hands)

  • Constipation

  • Liver enzyme elevation

  • Loss of appetite

  • Neuropathy (tingling, numbness)

  • Skin irritation (rare)

  • Blurred vision (rare)


🧠 My Clinical Approach

I avoid or modify the dose in:

  • Severe neuropathy

  • Pre-existing cardiac dysfunction

  • High-risk lung disease

⏱️ Side Effect Timeline

Side Effect

When It Appears

Nausea

Day 1

Infusion reaction

Immediate

Bone marrow suppression

Weeks

ILD (lung toxicity)

~5 months

💊 Drug Interactions

  • No major metabolic interactions

  • But additive bone marrow suppression possible



💉 Administration & Handling (Important)

  • Available as 100 mg vial

  • Refrigerate (2–8°C)

  • Protect from light

⚠️ Critical Preparation Rule

❌ Do NOT dilute in normal saline

✔️ Use sterile water provided

Infusion Protocol

  • First dose: 90 minutes infusion

  • Never push or give a bolus

👉 Fast infusion can cause:

  • Vomiting

  • Low BP

  • Dizziness

Premedication

  • Ondansetron / Granisetron

  • Dexamethasone

  • ± Aprepitant


🧠 Real-World Mistakes I See

  • The wrong HER2 drug was given

  • No baseline lung testing (PFT)

  • Ignoring mild early symptoms

  • Starting the drug without HER2 confirmation

  • Not recognizing HER2-low cases

  • Giving the infusion too fast



🧪 Do You Need HER2 Testing?

Yes, and sometimes repeat testing.

👉 Tumor biology can change

👉 HER2 may be reported as:

  • HER2

  • ERBB2


🌍 Global Consultation Reality

We receive:

  • Tissue samples from across India & abroad

  • Re-evaluation requests

👉 This prevents:

  • Unnecessary treatment

  • Wrong drug usage


🚨 When to Contact a Doctor Immediately

  • Breathlessness (especially after months of treatment)

  • Sudden cough

  • Dizziness or low BP

  • Uncontrolled vomiting

  • Severe pain



💰 Cost in India

  • Highly variable

  • Depends on:

    • Patient weight

    • Government schemes

    • Company support programs

👉 No fixed cost can be quoted



🧠 Why Patients Take a Second Opinion From Me

Because:

👉 This drug is powerful but complex

I help with:

  • Whether you really need it

  • Correct HER2 interpretation

  • Dose planning

  • Side effect decoding

  • Avoiding overtreatment


❓ FAQ

Is trastuzumab deruxtecan the same as Herceptin?

No, they are completely different drugs and not interchangeable.

What is HER2-low?

A newer category where even low HER2 expression responds to this drug.

What is the most serious side effect?

Lung toxicity (ILD), which needs early detection.

Can I take this during pregnancy?

No, it is strictly contraindicated.

🧾 Conclusion

Trastuzumab Deruxtecan is one of the most advanced targeted therapies available today.

But:

👉 It is not just about giving the drug👉 It is about selecting the right patient👉 Monitoring at the right time👉 Interpreting side effects correctly

👉 If you are considering this treatment:



Comments

bottom of page